These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28955188)

  • 1. Premenopausal Reproductive Health Modulates Future Cardiovascular Risk - Comparative Evidence from Monkeys and Women.
    Kaplan JR; Manuck SB
    Yale J Biol Med; 2017 Sep; 90(3):499-507. PubMed ID: 28955188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origins and health consequences of stress-induced ovarian dysfunction.
    Kaplan JR
    Interdiscip Top Gerontol; 2008; 36():162-85. PubMed ID: 18523378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian dysfunction and the premenopausal origins of coronary heart disease.
    Kaplan JR; Manuck SB
    Menopause; 2008; 15(4 Pt 1):768-76. PubMed ID: 18709705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.
    Clarkson TB
    Menopause; 2018 Nov; 25(11):1262-1274. PubMed ID: 30358722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.
    Clarkson TB
    Menopause; 2007; 14(3 Pt 1):373-84. PubMed ID: 17438515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproductive hormones and cardiovascular disease mechanism of action and clinical implications.
    Wagner JD; Kaplan JR; Burkman RT
    Obstet Gynecol Clin North Am; 2002 Sep; 29(3):475-93. PubMed ID: 12353669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease and ovarian function.
    Kallen AN; Pal L
    Curr Opin Obstet Gynecol; 2011 Aug; 23(4):258-67. PubMed ID: 21681091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary heart disease of females: lessons learned from nonhuman primates.
    Clarkson TB; Mehaffey MH
    Am J Primatol; 2009 Sep; 71(9):785-93. PubMed ID: 19382155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian dysfunction, stress, and disease: a primate continuum.
    Kaplan JR; Manuck SB
    ILAR J; 2004; 45(2):89-115. PubMed ID: 15111730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis.
    Tung KH; Wilkens LR; Wu AH; McDuffie K; Nomura AM; Kolonel LN; Terada KY; Goodman MT
    Am J Epidemiol; 2005 Feb; 161(4):321-9. PubMed ID: 15692075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of estrogen treatment on arterial wall structure and function.
    Clarkson TB; Anthony MS; Klein KP
    Drugs; 1994; 47 Suppl 2():42-51. PubMed ID: 7517833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus and cardiovascular disease in women.
    Sowers JR
    Arch Intern Med; 1998 Mar; 158(6):617-21. PubMed ID: 9521226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease is preventable among women.
    Kuller LH
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):175-87. PubMed ID: 20136604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models.
    Kaplan JR; Adams MR; Clarkson TB; Manuck SB; Shively CA; Williams JK
    Psychosom Med; 1996; 58(6):598-611. PubMed ID: 8948008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement.
    Stevenson JC
    Maturitas; 2011 Oct; 70(2):197-205. PubMed ID: 21788109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive System Outcome Among Patients with Polycystic Ovarian Syndrome.
    Carmina E
    Endocrinol Metab Clin North Am; 2015 Dec; 44(4):787-97. PubMed ID: 26568493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaps, limitations and new insights on endogenous estrogen and follicle stimulating hormone as related to risk of cardiovascular disease in women traversing the menopause: A narrative review.
    El Khoudary SR
    Maturitas; 2017 Oct; 104():44-53. PubMed ID: 28923176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative spinal bone mineral density changes and subclinical ovulatory disturbances--prospective data in healthy premenopausal women with regular menstrual cycles.
    Li D; Hitchcock CL; Barr SI; Yu T; Prior JC
    Epidemiol Rev; 2014; 36():137-47. PubMed ID: 24275546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause.
    Sutton-Tyrrell K; Lassila HC; Meilahn E; Bunker C; Matthews KA; Kuller LH
    Stroke; 1998 Jun; 29(6):1116-21. PubMed ID: 9626281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the menopause on the epidemiology and risk factors of coronary artery heart disease in women.
    Gorodeski GI
    Exp Gerontol; 1994; 29(3-4):357-75. PubMed ID: 7925756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.